---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-000106"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2026-01-02T23:59:59+00:00"
generated_at: "2026-05-16T11:50:25.320695+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Three Indaptus Therapeutics directors resign pending stockholder vote on Lazar nominees

## Summary
- Directors Michael Newman, Mark Gilbert, Anthony Maddaluna resigned effective upon approval of David Lazar's nominees at next stockholder meeting.
- Resignations not due to any disagreement with Company, management, Board, or committees.
- Board changes likely part of ongoing activist or settlement with David Lazar.

## SEC filing metadata
- accession: 0001493152-26-000106
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2026-01-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000149315226000106/0001493152-26-000106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000149315226000106/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-000106
- JSON: https://secwatch.observer/filing/0001493152-26-000106.json
- Plain text: https://secwatch.observer/filing/0001493152-26-000106.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.